Form 483

Stembanc Inc Form 483, 2010-04-27

FDA issued a Form 483 to Stembanc Inc on 2010-04-27 with 9 public-safe observations.

483· Form 483 issued9 observations

Stembanc Inc · Chardon, United States · Issued April 27, 2010

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

27 Apr 2010
21 CFR 1271.60(a)

Completion of eligibility determination

Cited by Stephen J Kilker

27 Apr 2010
21 CFR 1271.65(a)

Improper release prevention--storage, I.D.

Cited by Stephen J Kilker

27 Apr 2010
21 CFR 1271.75(a)(1)

Risk factors, clinical evidence

Cited by Stephen J Kilker

27 Apr 2010
21 CFR 1271.80(c)

Manufacturer instructions not followed

Cited by Stephen J Kilker

27 Apr 2010
21 CFR 1271.80(d)(2)

Plasma diluted test specimens

Cited by Stephen J Kilker

Inspected site

SIStembanc IncChardon, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.150(c)(1)(iii)Cited across public-safe Form 483 observations1x
21 CFR 1271.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 1271.160(b)(6)Cited across public-safe Form 483 observations1x
21 CFR 1271.180(c)Cited across public-safe Form 483 observations1x
21 CFR 1271.60(a)Cited across public-safe Form 483 observations1x
21 CFR 1271.65(a)Cited across public-safe Form 483 observations1x
21 CFR 1271.75(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 1271.80(c)Cited across public-safe Form 483 observations1x
21 CFR 1271.80(d)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere